Today: 11 July 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

NextEra Energy (NEE) Stock Week Ahead: Data-Center Deals, Updated Forecasts, Analyst Targets, and Key Risks for Dec. 22–26, 2025

NextEra Energy (NEE) Stock Week Ahead: Data-Center Deals, Updated Forecasts, Analyst Targets, and Key Risks for Dec. 22–26, 2025

NextEra Energy, Inc. heads into a holiday-shortened week with investors balancing two forces that often pull utility stocks in opposite directions: rapidly rising power demand tied to AI and data centers and the interest-rate/policy backdrop. The stock last closed at $79.54 on Friday, Dec. 19, after a 1.62% decline on the day, while trading volume jumped well above its recent average. MarketWatch
22 December 2025
··
ON Semiconductor Stock (NASDAQ: ON) Week Ahead Outlook: Nasdaq-100 Exit, Buybacks, and GaN Catalysts to Watch (Dec. 22–26, 2025)

ON Semiconductor Stock (NASDAQ: ON) Week Ahead Outlook: Nasdaq-100 Exit, Buybacks, and GaN Catalysts to Watch (Dec. 22–26, 2025)

ON Semiconductor Corporation heads into a holiday-shortened trading week with two unusual forces likely to dominate price action: index-driven flows tied to ON’s removal from the Nasdaq-100, and a steady drumbeat of strategic announcements aimed at power semiconductors for AI infrastructure, EVs, and industrial energy systems.
22 December 2025
··
Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals (VRTX) Stock Week Ahead: Holiday-Shortened Trading, New Gene-Therapy Data, and Fresh Analyst Targets (Dec. 22–26, 2025)

Vertex Pharmaceuticals Incorporated heads into the week of December 22–26, 2025 with a familiar setup for biotech investors: a cash-rich market leader in cystic fibrosis, a pipeline that could meaningfully diversify revenue over the next 12–24 months, and a stock that can move quickly on headlines—even when broader markets are quiet.
22 December 2025
Coca-Cola (KO) Stock Week Ahead (Dec 22–26, 2025): CEO Succession, Costa Coffee Sale Talks, Analyst Targets, and Key Levels to Watch

Coca-Cola (KO) Stock Week Ahead (Dec 22–26, 2025): CEO Succession, Costa Coffee Sale Talks, Analyst Targets, and Key Levels to Watch

As the new week begins, The Coca-Cola Company heads into a holiday-shortened stretch with the stock hovering around $70 and investors weighing a mix of corporate headlines, analyst updates, and a macro calendar that could sway defensive names. KO last traded around $70.06 heading into the weekend, keeping the beverage giant firmly in “steady compounder” territory as markets prepare for lighter liquidity around Christmas.
22 December 2025
Coinbase (COIN) Stock Week Ahead: Stock-Trading Rollout, Prediction-Market Lawsuits, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

Coinbase (COIN) Stock Week Ahead: Stock-Trading Rollout, Prediction-Market Lawsuits, Analyst Targets and Key Catalysts for Dec. 22–26, 2025

NEW YORK — Sunday, Dec. 21, 2025. Coinbase Global, Inc. heads into the Christmas-shortened trading week with investor attention split between two forces: the crypto tape and Coinbase’s accelerating push to become an “everything exchange” spanning crypto, stocks, derivatives, and prediction markets.
22 December 2025
··
Carnival Corporation Stock Week Ahead (CCL): Dividend Return, Record 2025 Earnings, and the Key Catalysts to Watch Into Christmas Week

Carnival Corporation Stock Week Ahead (CCL): Dividend Return, Record 2025 Earnings, and the Key Catalysts to Watch Into Christmas Week

Carnival Corporation stock heads into the week of Dec. 22–26, 2025 with fresh momentum after a sharp post-earnings jump that pushed shares back toward multi-year highs. The move followed Carnival’s record full-year 2025 performance, a bullish 2026 profit outlook, and a headline-grabbing decision to reinstate its quarterly dividend for the first time since the pandemic-era suspension. Nasdaq+2PR Newswire+2
22 December 2025
·····
Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

Amicus Therapeutics (FOLD) Stock Week Ahead: $14.50 BioMarin Buyout Puts the Deal Spread—and New Filings—Front and Center (Dec. 22–26, 2025)

As of Sunday, December 21, 2025, Amicus Therapeutics, Inc. is no longer trading like a “typical biotech story stock.” After BioMarin’s all-cash $14.50-per-share takeover agreement, FOLD has effectively become a deal-driven, merger-arbitrage name—meaning next week’s action is likely to hinge less on quarterly fundamentals and more on the probability, timing, and conditions of closing. SEC+1
22 December 2025
····
Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Stock Forecast for the Week Ahead (Dec. 22–26, 2025): BIIB Near 52-Week High as Leqembi Momentum Meets an Analyst Split

Biogen Inc. heads into the Christmas week with its stock hovering just below a recent high, a fresh spike in trading volume, and a narrative that’s increasingly dominated by one question: can the company turn Leqembi’s momentum into a durable growth engine while legacy revenue lines mature and competition intensifies?
21 December 2025
··
1 … 705 706 707 708 709 … 880

Stock Market Today

  • Sensex Up 827 Points Led by Reliance, Banks; Nifty Gains 1%
    July 10, 2026, 9:10 PM EDT. The Sensex rose 827 points to finish at 77,569, marking its second straight day of gains. Reliance Industries, ICICI Bank, and HDFC Bank led the index higher. Softer crude prices and interest in IT helped lift stocks. The Nifty also added 1% as traders tracked firm global signals.
Go toTop